文献速递脑血管病外科神经重症

无框架立体定向放射外科治疗脑动静脉畸形的系统综述与荟萃分析

Frameless Stereotactic Radiosurgery (SRS) of Brain Arteriovenous Malformation (AVM); a Systematic Review, Meta-Analysis, and a Specific Analysis on Single-Session SRS.
PubMed 文献 · World Neurosurg · 2026-08-06

该系统综述与荟萃分析纳入11项研究共730例脑动静脉畸形患者,评估无框架立体定向放射外科的疗效与安全性。汇总完全闭塞率为64%(95%CI:59%-69%),放射不良反应率11%(95%CI:3%-18%),术后出血率3%(95%CI:2%-5%)。目前缺乏与框架式SRS等效性的比较证据。

要点

  • 无框架SRS治疗脑AVM的汇总完全闭塞率为64%(95%CI:59%-69%)。
  • 术后出血率低至3%(95%CI:2%-5%),但持续性神经功能缺损发生率为17%(95%CI:7%-27%)。
  • 无框架与框架式SRS仅在2项观察性研究中显示统计学相似,证据不足以确立等效性。

核心结论

  • 无框架SRS治疗选择性脑AVM的汇总完全闭塞率为64%,术后出血率低。
  • 目前缺乏比较证据以确立无框架SRS与框架式SRS的等效性。

研究设计与样本

  • 系统综述与荟萃分析,检索3个数据库至2026年2月8日。
  • 纳入11篇2009年至2024年的文献,共730例患者,部分结局按AVM或治疗靶点报告。
  • 主要结局为完全闭塞、放射不良反应和SRS后出血;汇总估计涵盖混合分割队列,单次分析仅限单次分割组。
  • 框架式观察仅用于2项研究的探索性头对头比较。

主要发现

  • 汇总完全闭塞率为64%(95%CI:59%-69%)。
  • 汇总放射不良反应率为11%(95%CI:3%-18%)。
  • 汇总SRS后出血率为3%(95%CI:2%-5%)。
  • 死亡率极低,为0.1%(95%CI:0.09%-0.11%);持续性神经功能缺损发生率为17%(95%CI:7%-27%)。
  • 在5项研究的探索性荟萃回归中,平均最大剂量与完全闭塞呈负相关(P=0.026,R2=100%)。

关键数值与推荐

  • 汇总完全闭塞率64%(95%CI:59%-69%),放射不良反应率11%(95%CI:3%-18%),SRS后出血率3%(95%CI:2%-5%)。
  • 死亡率0.1%(95%CI:0.09%-0.11%),持续性神经功能缺损率17%(95%CI:7%-27%)。
  • 平均最大剂量与完全闭塞的探索性荟萃回归:P=0.026,R2=100%(基于5项研究)。

临床怎么用

  • 无框架SRS可用于选择性脑AVM,但需严格患者选择、治疗计划和随访。
  • 术后出血率低,但需关注放射不良反应及持续性神经功能缺损风险。
  • 目前不应基于现有证据认为无框架SRS与框架式SRS等效。

局限性

  • 纳入研究数量有限(11项),部分结局按AVM或治疗靶点报告,可能存在数据重叠。
  • 缺乏与框架式SRS的大样本比较证据,仅2项观察性研究进行了头对头比较。
  • 平均最大剂量与完全闭塞的荟萃回归仅基于5项研究,为探索性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intracranial arteriovenous malformations (AVMs) are complex vascular lesions associated with hemorrhage, neurological morbidity, and mortality. This study evaluates the efficacy and safety of frameless stereotactic radiosurgery (SRS) for brain AVMs. METHODS: A comprehensive literature search was conducted across 3 databases through February 8, 2026. Primary outcomes included complete obliteration (CO), adverse radiation effects (AREs), and post-SRS hemorrhage. Pooled estimates included all extractable frameless SRS data, covering mixed-fraction cohorts. Analyses labeled as single-session referred to arms identified as single-fraction. Frame-based observations were only employed in one separate exploratory head-to-head comparison of 2 studies. RESULTS: Eleven publications from 2009 to 2024 were included, comprising 730 patients, although some outcomes were reported per AVM or treatment target. The pooled CO rate was 64% (95% CI: 59%-69%), the pooled ARE rate was 11% (95% CI: 3%-18%), and the pooled post-SRS hemorrhage rate was 3% (95% CI: 2%-5%). Mortality was rare (0.1%; 95% CI: 0.09%-0.11%), and persistent neurological deficits occurred in 17% (95% CI: 7%-27%). An inverse relationship was found between mean maximum dose and CO (P = 0.026, R2 = 100%) in an exploratory meta-regression of 5 studies. The frameless and frame-based SRS were found to be statistically similar in 2 observational comparative studies. CONCLUSIONS: The pooled CO rate for selected brain AVMs was 64%, and the hemorrhage rate after frameless SRS was low. Nonetheless, careful patient selection, treatment planning, and follow-up remain crucial. Currently, there is a lack of comparative evidence to establish equivalence with frame-based SRS.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Safari Dehnavi N, Kamroo A, Habibi MA, et al. Frameless Stereotactic Radiosurgery (SRS) of Brain Arteriovenous Malformation (AVM); a Systematic Review, Meta-Analysis, and a Specific Analysis on Single-Session SRS. World Neurosurg. 2026. PMID: 42562109. doi:10.1016/j.wneu.2026.125215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。